1. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials. (March 2023) Authors: Simões, Eric A F; Madhi, Shabir A; Muller, William J; Atanasova, Victoria; Bosheva, Miroslava; Cabañas, Fernando; Baca Cots, Manuel; Domachowske, Joseph B; Garcia-Garcia, Maria L; Grantina, Ineta; Nguyen, Kim A; Zar, Heather J; Berglind, Anna; Cummings, Celeste; Griffin, M Pamela; Takas, Therese;... Journal: Lancet Issue: Volume 7:Number 3(2023) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗